Company Overview
Snapshot
Founded in January 2016 by Ariel Hasidim, EifoDefi operates with 1–10 employees. The company has secured funding across one disclosed round from one investor. In May 2020, EifoDefi received a Seed funding round from Cactus Capital.
Business overview
EifoDefi develops a social defibrillator mapping application designed to collaboratively map automated external defibrillators (AEDs). The company's core technology is a mobile, location-based alert system that makes public AEDs accessible to everyone. EifoDefi serves the healthcare market, specifically patients, within the Health Tech & Life Sciences sector, focusing on Digital Healthcare and Digital Accessibility Solutions in Israel.
Strategic signal
In February 2022, EifoDefi was featured in a Jerusalem Post article highlighting its mission to save lives by making defibrillators more accessible. This media coverage underscores the company's public health impact and its potential for broader adoption and community engagement in critical care, signaling strong social validation and a clear value proposition for investors interested in health tech with a direct societal benefit.
Log in to access full profile ›Company Intelligence Q&A
- What is EifoDefi's primary offering?
- EifoDefi provides a social defibrillator mapping application that enables collaborative mapping of automated external defibrillators (AEDs) to make them accessible to the public.
- When was EifoDefi founded and by whom?
- EifoDefi was founded in January 2016 by Ariel Hasidim, who serves as Co-founder & CEO.
- What is the primary geographic market for EifoDefi's solution?
- EifoDefi's primary geographic market is Israel, where its app is currently in use.
- What is the strategic importance of EifoDefi's mobile application?
- The EifoDefi mobile application is critical for public health, as it allows for the real-time tracking and accessibility of defibrillators, which can be life-saving in cardiac emergencies.